about
Gene therapy: light is finally in the tunnelRecombinant vaccines against T. gondii: comparison between homologous and heterologous vaccination protocols using two viral vectors expressing SAG1Progress and prospects: immune responses to viral vectorsPre-clinical evaluation of a replication-competent recombinant adenovirus serotype 4 vaccine expressing influenza H5 hemagglutininAdeno-associated viral vector-mediated transgene expression is independent of DNA methylation in primate liver and skeletal muscleDefects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus.Vimentin knockdown decreases corneal opacity.Targeting the TLR9-MyD88 pathway in the regulation of adaptive immune responses.Selectivity of oncolytic viral replication prevents antiviral immune response and toxicity, but does not improve antitumoral immunity.The human adenovirus type 5 E1B 55 kDa protein obstructs inhibition of viral replication by type I interferon in normal human cells.NKG2D is required for NK cell activation and function in response to E1-deleted adenovirusTNF-alpha promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells.Negative regulation of IRF7 activation by activating transcription factor 4 suggests a cross-regulation between the IFN responses and the cellular integrated stress responses.The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirusLentiviral gene transfer into the dorsal root ganglion of adult rats.The role of endosomal escape and mitogen-activated protein kinases in adenoviral activation of the innate immune response.A new human DSG2-transgenic mouse model for studying the tropism and pathology of human adenoviruses.Myeloid-derived suppressor cells regulate natural killer cell response to adenovirus-mediated gene transferNanoparticle delivery systems in cancer vaccines.Evading the immune response upon in vivo gene therapy with viral vectors.Therapeutic margins in a novel preclinical model of retinitis pigmentosa.DRG-targeted helper-dependent adenoviruses mediate selective gene delivery for therapeutic rescue of sensory neuronopathies in mice.Coxsackievirus B3 Directly Induced Th17 Cell Differentiation by Inhibiting Nup98 Expression in Patients with Acute Viral Myocarditis.A new link between virus cell entry and inflammation: adenovirus interaction with integrins induces specific proinflammatory responses.Long-term virus-induced alterations of CYP3A-mediated drug metabolism: a look at the virology, immunology and molecular biology of a multi-faceted problem.Innate Immune Responses to AAV VectorsTargeting co-stimulatory pathways in gene therapyDrug delivery systems for the treatment of ischemic stroke.Recent advances in antibody-inducing poxviral and adenoviral vectored vaccine delivery platforms for difficult disease targets.Lentiviral vectors and cystic fibrosis gene therapyTargeted delivery of growth factors in ischemic stroke animal models.Gene delivery targeted to oligodendrocytes using a lentiviral vector.Activation of transgene-specific T cells following lentivirus-mediated gene delivery to mouse lung.Vector modifications to eliminate transposase expression following piggyBac-mediated transgenesisOligonucleotides designed to inhibit TLR9 block Herpes simplex virus type 1 infection at multiple steps.Development of an adenovirus vector vaccine platform for targeting dendritic cells.Bioreducible Poly-L-Lysine-Poly[HPMA] Block Copolymers Obtained by RAFT-Polymerization as Efficient Polyplex-Transfection Reagents.
P2860
Q27000091-BC9285EA-9716-4975-B897-A8B72ECEFCB3Q27321063-61DCE6E3-FD76-4EFB-B50D-B52DAA6433ADQ28264531-BFD142D0-41E1-4824-8841-CA704C08630FQ28731982-EA33A806-E9F2-42B7-9C12-BF0436A61E18Q28743855-6E80E6BE-CA8A-4896-A3A3-582B62D06646Q33747762-853A991A-CA04-4717-B4AF-437B2FEBFB62Q33835659-0148BB11-93D9-493D-AF21-D5CF439720BAQ34048648-66E5E20D-98C9-4A73-96A7-BAC6FA6DC21AQ34343742-BACD7A80-6894-44F3-8A21-ABF99808B807Q34388476-EDD8BB18-B19C-4833-9C1C-92D67D4BCBD0Q34432661-C70381EB-0F87-486E-8951-B79436502614Q34534156-6B34C392-DB44-483A-835F-8EC230245109Q34670715-7B6CF879-372F-4FCC-AC99-C7443DDFF7BBQ35177864-5276E811-FB68-4D1B-913B-CE30D76FF736Q35231284-9C3D0696-EDAD-4302-A202-882B4E63B4EAQ35462794-D95196F9-2804-4EA7-B64C-62486AE821BCQ36023115-E69B4478-B376-4994-92DF-04C26B96A1E6Q36414429-4ED7A44C-EE81-404B-B3A2-1CC3F5443BA2Q36574571-BAF20060-6FED-494A-BDE9-F9B9323AE540Q36644230-C7A91E6D-0A96-4094-9068-9EED92B64612Q37093907-0BF4FBD5-C6BE-459F-ACC9-973A1B8A6FE3Q37241434-27EDF920-2877-4177-AED4-A95B5FDCA251Q37486647-AD962CE9-EBF9-476F-8751-75A9901C83C5Q37590085-05A6634A-6AE6-43BE-9502-AF84B718D2E8Q37592262-22F5D349-8B32-4EEA-A6DD-5B586319FBA1Q37939843-186AE9F3-D65B-41C5-8D1C-62122C0C0C9DQ37951935-CB01A8A5-F4D8-4E75-B532-C272BF450C99Q38073181-23AA03CB-9016-45C6-902F-CEB065418079Q38096489-A9BEE934-659A-4AAC-AB88-FCB909D5EC35Q38614351-2DB7B9B6-A8DC-4F93-ABB9-9FCB161A0837Q38703863-42F9892D-EFFD-4A35-BAD9-85AF63221059Q39098445-2154E88F-07C1-48C6-8657-3A97171DF40CQ39639271-B42DB80D-066A-48B6-ADC4-AAB6E1D7E4F3Q42177240-87C76B78-4AF0-4195-9193-A6B8BC123DFBQ42207445-059ED4E8-4105-4A21-8852-28305E49C0B6Q47248134-DB005B62-62A3-4456-B09F-4DC35BF5DA80Q53925499-F1CBA855-83C6-4313-9526-683D58DEA254
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Innate immune recognition of viruses and viral vectors.
@ast
Innate immune recognition of viruses and viral vectors.
@en
type
label
Innate immune recognition of viruses and viral vectors.
@ast
Innate immune recognition of viruses and viral vectors.
@en
prefLabel
Innate immune recognition of viruses and viral vectors.
@ast
Innate immune recognition of viruses and viral vectors.
@en
P2860
P356
P1433
P1476
Innate immune recognition of viruses and viral vectors.
@en
P2093
Xiaopei Huang
Yiping Yang
P2860
P304
P356
10.1089/HUM.2008.141
P577
2009-04-01T00:00:00Z